Position in TEVA
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$1,094,315,631
-$3,744,207 QoQ
Shares Held
32,299,753
-8.2% QoQ
Ownership
2.77%
of shares outstanding
% of Portfolio
0.11%
of 13F equity value
Holder Rank
#8
of 671 holders
Holding Since
Mar 2020
23 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in TEVA Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Jun 30, 2026NORGES BANK holds $2,351,821,288 across 19 Drug Manufacturers - Specialty & Generic names. TEVA ranks #1 (46.5% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | TEVA |
Teva Pharmaceutical Industries Ltd
This page
|
32,299,753 | $1,094,315,631 | |
| 2 | UTHR |
UNITED THERAPEUTICS Corp
|
694,753 | $376,438,017 | |
| 3 | ZTS |
Zoetis Inc.
|
4,689,847 | $337,012,405 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
973,880 | $164,137,735 | |
| 5 | ALKS |
Alkermes plc.
|
2,156,814 | $113,017,053 | |
| 6 | HLN |
Haleon plc
|
7,175,000 | $66,942,750 | |
| 7 | LNTH |
Lantheus Holdings, Inc.
|
586,845 | $65,104,584 | |
| 8 | VTRS |
Viatris Inc
|
3,822,744 | $60,705,174 |
All Filings in TEVA
Export CSV
23 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,094,315,631 | 32,299,753 | Shares | Sole | 2026-08-12 | |
| 2025-12-31 | $1,098,059,838 | 35,182,949 | Shares | Sole | 2026-02-10 | |
| 2025-06-30 | $31,252,103 | 1,864,684 | Shares | Sole | 2025-08-13 | |
| 2025-03-31 | $39,734,524 | 2,585,200 | Shares | Sole | 2026-05-11 | |
| 2024-12-31 | $38,549,502 | 1,749,070 | Shares | Sole | 2025-02-12 | |
| 2024-09-30 | $27,319,581 | 1,516,070 | Shares | Sole | 2025-11-12 | |
| 2024-06-30 | $17,450,891 | 1,073,901 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $8,536,550 | 605,000 | Shares | Sole | 2025-05-14 | |
| 2023-12-31 | $14,375,880 | 1,377,000 | Shares | Sole | 2024-02-09 | |
| 2023-09-30 | $10,638,600 | 1,043,000 | Shares | Sole | 2024-11-13 | |
| 2023-06-30 | $83,906,993 | 11,143,027 | Shares | Sole | 2024-08-14 | |
| 2023-03-31 | $29,231,550 | 3,303,000 | Shares | Sole | 2024-05-15 | |
| 2022-12-31 | $10,150,560 | 1,113,000 | Shares | Sole | 2023-02-14 | |
| 2022-09-30 | $7,222,650 | 895,000 | Shares | Sole | 2023-11-13 | |
| 2022-06-30 | $2,331,200 | 310,000 | Shares | Sole | 2023-08-14 | |
| 2021-12-31 | $1,204,031 | 150,316 | Shares | Sole | 2022-03-09 | |
| 2021-09-30 | $2,934,788 | 301,313 | Shares | Sole | 2022-11-14 | |
| 2021-06-30 | $26,113,824 | 2,637,760 | Shares | Sole | 2022-08-15 | |
| 2021-03-31 | $30,439,750 | 2,637,760 | Shares | Sole | 2022-05-09 | |
| 2020-12-31 | $29,731,688 | 3,081,004 | Shares | Sole | 2021-03-02 | |
| 2020-09-30 | $25,018,472 | 2,776,745 | Shares | Sole | 2021-11-12 | |
| 2020-06-30 | $22,461,400 | 1,821,687 | Shares | Sole | 2021-08-13 | |
| 2020-03-31 | $76,125,722 | 8,477,252 | Shares | Sole | 2021-05-07 | |
| No filing history on record for this holder in this stock. | ||||||